A new drug therapy for young children who suffer with "moderate to severe" eczema has been proven to work well during clinical trials.
The drug therapy, called dupilumab, reportedly improved the severity of the skin condition within just two weeks.
Based on the results, which were published in the international medical journal The Lancet, the treatment may soon be approved in the UK for children under six years old.
